Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-318
Closed -$22.3K 4731
2023
Q1
$22.3K Hold
318
﹤0.01% 4672
2022
Q4
$25.9K Hold
318
﹤0.01% 4690
2022
Q3
$26K Hold
318
﹤0.01% 4789
2022
Q2
$50K Buy
318
+15
+5% +$3.55K ﹤0.01% 4724
2022
Q1
$114K Hold
303
﹤0.01% 4606
2021
Q4
$118K Hold
303
﹤0.01% 4538
2021
Q3
$227K Hold
303
﹤0.01% 4312
2021
Q2
$317K Buy
303
+270
+818% +$323K ﹤0.01% 4027
2021
Q1
$48K Buy
+33
New +$48K ﹤0.01% 3941
2020
Q2
Sell
-946
Closed -$317K 3866
2020
Q1
$317K Buy
946
+502
+113% +$198K ﹤0.01% 3519
2019
Q4
$361K Buy
444
+26
+6% +$31.2K ﹤0.01% 3561
2019
Q3
$596K Buy
418
+62
+17% +$99.4K ﹤0.01% 3479
2019
Q2
$602K Buy
+356
New +$723K ﹤0.01% 3486

Other funds holding YCBD

State Street's YCBD Position: Q2 2023 in Review

State Street sold out of cbdMD (YCBD) in Q2 2023, closing a stake of 318 shares — an estimated $22.3K sold.

State Street first reported a position in YCBD in Q2 2019 and held it in 13 quarters. The position peaked at $602K in Q2 2019. 20 funds tracked by Wall St. Rank hold YCBD as of Q2 2023.

  • State Street reported no remaining cbdMD position as of Q2 2023 after selling out during the quarter.
  • State Street sold 318 cbdMD shares in Q2 2023, an estimated $22.3K.
  • State Street first reported a position in cbdMD in Q2 2019 and held it in 13 quarters.
  • State Street's cbdMD position peaked at $602K in Q2 2019.
  • 20 funds tracked by Wall St. Rank held cbdMD as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.